Q2 Earnings Estimate for Revvity Issued By Leerink Partnrs

Revvity, Inc. (NYSE:RVTY - Free Report) - Analysts at Leerink Partnrs lowered their Q2 2025 EPS estimates for Revvity in a note issued to investors on Monday, April 28th. Leerink Partnrs analyst P. Souda now anticipates that the company will earn $1.14 per share for the quarter, down from their prior estimate of $1.22. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity's Q3 2025 earnings at $1.25 EPS, Q1 2026 earnings at $1.15 EPS and Q3 2026 earnings at $1.39 EPS.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.96 by $0.05. The firm had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The business's revenue for the quarter was up 2.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.98 EPS.

Several other equities analysts have also commented on the stock. Robert W. Baird decreased their price objective on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. UBS Group raised Revvity from a "neutral" rating to a "buy" rating and dropped their price objective for the company from $145.00 to $115.00 in a research note on Thursday. Wells Fargo & Company lowered their target price on Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a report on Thursday, April 17th. KeyCorp boosted their price target on shares of Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Finally, Barclays dropped their price objective on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Revvity has an average rating of "Moderate Buy" and a consensus price target of $125.64.

Revvity Trading Down 0.7 %

RVTY traded down $0.66 on Wednesday, hitting $93.33. The company had a trading volume of 207,740 shares, compared to its average volume of 928,220. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The firm has a market cap of $11.21 billion, a P/E ratio of 42.28, a PEG ratio of 3.82 and a beta of 1.07. The company's fifty day moving average price is $102.80 and its 200 day moving average price is $112.02. Revvity has a 1 year low of $88.53 and a 1 year high of $129.50.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Victory Capital Management Inc. grew its position in Revvity by 17.4% during the 4th quarter. Victory Capital Management Inc. now owns 70,250 shares of the company's stock worth $7,841,000 after purchasing an additional 10,390 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Revvity by 13.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company's stock worth $43,961,000 after purchasing an additional 41,497 shares in the last quarter. Contravisory Investment Management Inc. boosted its stake in shares of Revvity by 1,715.9% during the fourth quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company's stock valued at $7,722,000 after acquiring an additional 65,376 shares during the last quarter. Janney Montgomery Scott LLC raised its position in shares of Revvity by 87.0% in the fourth quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock valued at $881,000 after buying an additional 3,672 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in Revvity by 41.5% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,072 shares of the company's stock valued at $1,352,000 after acquiring an additional 3,542 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company's stock.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.30%. The ex-dividend date is Friday, July 18th. Revvity's payout ratio is currently 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.